OVC Nov 2025: AMD research: what’s new, what’s next? (Recorded Webcast)
Available from: 16/11/2025 (AEDT)
Where to publish: https://lms.optometry.org.au/course/view.php?id=946
Provider: OA National Provider
Contact: Optometry Australia Optometry Australia, [E] cpd@optometry.org.au, [P] 96688550
Activity Outline
This presentation will explore recent developments in AMD research, including the use of new large-scale resources such as the UK Biobank and the application of artificial intelligence to uncover new risk factors, predict disease progression, and personalise patient care. We will also examine research updates to clinical guidelines such as refinements to the AREDS risk score calculator incorporating reticular pseudodrusen and review emerging treatments for geographic atrophy, including recently approved pharmacological interventions. By the end of the session, attendees will have an understanding of how these innovations are shaping the future of AMD detection, prognosis, and treatment, and how this research may alter daily clinical practices relating to AMD.
Learning Objectives
- Evaluate how emerging research tools are transforming clinical management and treatment prospects for AMD
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| AMD research: what's new, what's next? |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.5 |